Guidance

IAPS Guidance for HSST trainees

Last Updated: 17th September 2020

Elements of the IAPS

The methodology used for the IAPS is the professional discussion (PD). The IAPS will consist of three elements:

1. A pre-PD element

On this element, you are being assessed on your submitted evidence.

Review of your submitted showcase evidence by the Lead Examiner for your specialty to ensure evidence appropriately maps to the GSP domain for which it was submitted and that at least 5 separate activities have been evidenced.

2. PD Element 1 – review of a specialist or service-based paper

On this element, you are being assessed on your critical reasoning, scientific integrity and vision.

Review of a previously unidentified specialist research or service-based paper (60 minutes) followed by a professional discussion with the examination panel (30 minutes).

This component will require you to respond to the following standard statement made to start your discussion:

‘Please discuss with us [the panel] the key points of interest to you as a Consultant Clinical Scientist that you elicited from the paper in your review.  We [the panel] would like to understand your reasoning as part of your discussion. We [the panel examiners] may come in with supplementary questions as appropriate to the discussion.’

3. PD Element 2 – meeting the Higher Specialist Scientist Standards of Proficiency

On this element, you are being assessed on your development to Consultant Clinical Scientist level.

You will be expected to demonstrate your development to consultant clinical scientist level against each GSP domain via a professional discussion with the examination panel using the submitted evidence as a basis for the discussion (60 minutes).

This component will require you to address the following standard statement to start the discussion under each GSP domain:

‘With reference to the evidence you submitted, please tell us how this demonstrates your development to Consultant Clinical Scientist level on the [name of domain] domain.’